Sotera Health Company
SHC
$15.11
-$0.65-4.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.16B | 1.15B | 1.12B | 1.11B | 1.10B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.16B | 1.15B | 1.12B | 1.11B | 1.10B |
| Cost of Revenue | 518.08M | 506.40M | 500.09M | 496.18M | 498.15M |
| Gross Profit | 645.53M | 643.98M | 624.44M | 610.61M | 602.30M |
| SG&A Expenses | 205.17M | 200.98M | 202.68M | 200.82M | 202.13M |
| Depreciation & Amortization | 30.74M | 43.10M | 55.52M | 61.63M | 62.04M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 753.99M | 750.47M | 758.29M | 758.63M | 762.32M |
| Operating Income | 409.63M | 399.91M | 366.25M | 348.16M | 338.13M |
| Income Before Tax | 147.51M | 121.97M | 91.79M | 88.04M | 113.87M |
| Income Tax Expenses | 69.56M | 66.55M | 67.77M | 63.22M | 69.48M |
| Earnings from Continuing Operations | 77.95 | 55.43 | 24.02 | 24.82 | 44.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 77.95M | 55.43M | 24.02M | 24.82M | 44.40M |
| EBIT | 409.63M | 399.91M | 366.25M | 348.16M | 338.13M |
| EBITDA | 548.66M | 546.86M | 527.94M | 514.74M | 504.40M |
| EPS Basic | 0.27 | 0.20 | 0.08 | 0.09 | 0.16 |
| Normalized Basic EPS | 0.57 | 0.52 | 0.44 | 0.40 | 0.38 |
| EPS Diluted | 0.27 | 0.19 | 0.08 | 0.08 | 0.15 |
| Normalized Diluted EPS | 0.57 | 0.52 | 0.44 | 0.40 | 0.37 |
| Average Basic Shares Outstanding | 1.14B | 1.13B | 1.13B | 1.13B | 1.13B |
| Average Diluted Shares Outstanding | 1.14B | 1.14B | 1.14B | 1.14B | 1.14B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |